B.M.J. Cantwell

A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation with anti-emetic response

J Carmichael, B.M.J. Cantwell, CM Edwards et al. · Cancer Chemotherapy and Pharmacology · 1989 · 167 citations

Anti-emetic Response, Brl 43694A, Functional Selectivity +6

Suppression of Postmenopausal Ovarian Steroidogenesis With the Luteinizing Hormone-Releasing Hormone Agonist Goserelin*

Mitch Dowsett, B.M.J. Cantwell, A. Lal et al. · The Journal of Clinical Endocrinology & Metabolism · 1988 · 113 citations

Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study

M.J. Millward, B.M.J. Cantwell, N.C. Munro et al. · British Journal of Cancer · 1993 · 89 citations · Full text

Oncology, Medicine, Metronomic Therapy +6

Comparison of short-term and continuous chemotherapy (mitozantrone) for advanced breast cancer

Adrian L. Harris, J Carmichael, J R Farndon et al. · The Lancet · 1990 · 86 citations

Advanced Breast Cancer, Breast Oncology, Oncology +8

Serum sialic acid and CEA concentrations in human breast cancer

Antoinette Hogan-Ryan, J. J. Fennelly, Michael E. Jones et al. · British Journal of Cancer · 1980 · 85 citations · Full text

Tumor Biology, Breast Oncology, Serum Sialic Acid +8